Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.931 |
High Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.9178 |
High Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8896 |
High Similarity |
NPD3749 |
Approved |
0.8836 |
High Similarity |
NPD1243 |
Approved |
0.8819 |
High Similarity |
NPD1510 |
Phase 2 |
0.8767 |
High Similarity |
NPD1549 |
Phase 2 |
0.8759 |
High Similarity |
NPD2796 |
Approved |
0.8699 |
High Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8699 |
High Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8699 |
High Similarity |
NPD2344 |
Approved |
0.8693 |
High Similarity |
NPD7411 |
Suspended |
0.8671 |
High Similarity |
NPD1240 |
Approved |
0.8645 |
High Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8627 |
High Similarity |
NPD4380 |
Phase 2 |
0.8581 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8553 |
High Similarity |
NPD920 |
Approved |
0.8552 |
High Similarity |
NPD1607 |
Approved |
0.8535 |
High Similarity |
NPD7075 |
Discontinued |
0.8533 |
High Similarity |
NPD643 |
Clinical (unspecified phase) |
0.8477 |
Intermediate Similarity |
NPD1511 |
Approved |
0.8471 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.8467 |
Intermediate Similarity |
NPD2309 |
Approved |
0.8462 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.8462 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8456 |
Intermediate Similarity |
NPD2800 |
Approved |
0.8447 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.8421 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.84 |
Intermediate Similarity |
NPD3750 |
Approved |
0.8397 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.8366 |
Intermediate Similarity |
NPD1512 |
Approved |
0.8364 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.8354 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.8344 |
Intermediate Similarity |
NPD2801 |
Approved |
0.8333 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.8302 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.828 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8261 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.8235 |
Intermediate Similarity |
NPD6799 |
Approved |
0.8137 |
Intermediate Similarity |
NPD919 |
Approved |
0.8121 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.8095 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.8086 |
Intermediate Similarity |
NPD5494 |
Approved |
0.8072 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8067 |
Intermediate Similarity |
NPD3748 |
Approved |
0.8067 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.8049 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.8038 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.8037 |
Intermediate Similarity |
NPD1247 |
Approved |
0.8027 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.8026 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8013 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.8013 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.8 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.8 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7988 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7952 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.795 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7949 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7949 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7949 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7933 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7905 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.787 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7848 |
Intermediate Similarity |
NPD5403 |
Approved |
0.784 |
Intermediate Similarity |
NPD2296 |
Approved |
0.7829 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7816 |
Intermediate Similarity |
NPD4287 |
Approved |
0.7808 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7806 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7791 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7785 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7778 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7778 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7771 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7755 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7751 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7751 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7751 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.775 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7727 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7722 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7712 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7712 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7706 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7706 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7692 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7682 |
Intermediate Similarity |
NPD943 |
Approved |
0.7667 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7667 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7661 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7651 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7625 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7622 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7616 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7613 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7613 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.7603 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7602 |
Intermediate Similarity |
NPD1729 |
Discontinued |
0.76 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7598 |
Intermediate Similarity |
NPD4361 |
Phase 2 |
0.7598 |
Intermediate Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.7588 |
Intermediate Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.758 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7572 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7568 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7534 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7534 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7533 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7516 |
Intermediate Similarity |
NPD2654 |
Approved |
0.75 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.75 |
Intermediate Similarity |
NPD6280 |
Approved |
0.75 |
Intermediate Similarity |
NPD6279 |
Approved |
0.7471 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7459 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7456 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7455 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7451 |
Intermediate Similarity |
NPD4307 |
Phase 2 |
0.7444 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7444 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7436 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7436 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7436 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7436 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7415 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.741 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7403 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7403 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7391 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7383 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7358 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7356 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7353 |
Intermediate Similarity |
NPD6808 |
Phase 2 |
0.7353 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7353 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7349 |
Intermediate Similarity |
NPD5760 |
Phase 2 |
0.7349 |
Intermediate Similarity |
NPD5761 |
Phase 2 |
0.7333 |
Intermediate Similarity |
NPD3267 |
Approved |
0.7333 |
Intermediate Similarity |
NPD3266 |
Approved |
0.7333 |
Intermediate Similarity |
NPD1164 |
Approved |
0.7329 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7317 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7303 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7273 |
Intermediate Similarity |
NPD6585 |
Discontinued |
0.7248 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7248 |
Intermediate Similarity |
NPD3972 |
Approved |
0.7229 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7219 |
Intermediate Similarity |
NPD1470 |
Approved |
0.7212 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7208 |
Intermediate Similarity |
NPD411 |
Approved |
0.7208 |
Intermediate Similarity |
NPD1296 |
Phase 2 |
0.72 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7196 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7193 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.719 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7181 |
Intermediate Similarity |
NPD1201 |
Approved |
0.7179 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7179 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7179 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7168 |
Intermediate Similarity |
NPD2403 |
Approved |
0.7168 |
Intermediate Similarity |
NPD4575 |
Clinical (unspecified phase) |
0.7151 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7143 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7134 |
Intermediate Similarity |
NPD5049 |
Phase 3 |
0.7126 |
Intermediate Similarity |
NPD5890 |
Approved |
0.7126 |
Intermediate Similarity |
NPD5889 |
Approved |
0.7124 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7123 |
Intermediate Similarity |
NPD9493 |
Approved |
0.7118 |
Intermediate Similarity |
NPD6971 |
Discontinued |
0.711 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7099 |
Intermediate Similarity |
NPD2354 |
Approved |
0.7097 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7086 |
Intermediate Similarity |
NPD7177 |
Discontinued |
0.7086 |
Intermediate Similarity |
NPD5940 |
Clinical (unspecified phase) |
0.7086 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.707 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7049 |
Intermediate Similarity |
NPD3269 |
Clinical (unspecified phase) |
0.7047 |
Intermediate Similarity |
NPD17 |
Approved |
0.7044 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7039 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7039 |
Intermediate Similarity |
NPD1876 |
Approved |
0.7039 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7034 |
Intermediate Similarity |
NPD1241 |
Discontinued |
0.7033 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7029 |
Intermediate Similarity |
NPD3446 |
Phase 1 |
0.7022 |
Intermediate Similarity |
NPD6104 |
Discontinued |
0.7022 |
Intermediate Similarity |
NPD3658 |
Clinical (unspecified phase) |
0.7019 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.7006 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7006 |
Intermediate Similarity |
NPD1613 |
Approved |
0.6987 |
Remote Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.6982 |
Remote Similarity |
NPD6844 |
Discontinued |
0.6982 |
Remote Similarity |
NPD7577 |
Discontinued |
0.698 |
Remote Similarity |
NPD4196 |
Clinical (unspecified phase) |
0.6974 |
Remote Similarity |
NPD4377 |
Discontinued |
0.6971 |
Remote Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.697 |
Remote Similarity |
NPD7447 |
Phase 1 |
0.6962 |
Remote Similarity |
NPD6355 |
Discontinued |
0.6959
|
Remote Similarity |
NPD4947 |
Clinical (unspecified phase) |